Plant Virology Applications in Human Health

A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viruses of Plants, Fungi and Protozoa".

Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 174

Special Issue Editors

Department of Cell and Systems Biology, Cornell University, Ithaca, NY 14850, USA
Interests: plant biotechnology; transgenic plant vaccine; plant virus nanoparticles for anti-cancer therapy
Special Issues, Collections and Topics in MDPI journals
Virology Laboratory, Department of Cell & Systems Biology, University of Toronto, Toronto, ON M5S 3B2, Canada
Interests: virology; plant viruses; viroids; satellites; agricultural biotechnology; genetic engineering; food security; virus-like particles; viral nanoparticles
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

As the global population approaches 10 billion people over the next few decades, it is critical that new innovations be explored to address issues concerning human health. The proportion of elderly people will increase, and along with that, chronic diseases such as high blood pressure and cancer will become more commonplace. Medical infrastructures will be overwhelmed with the increase in patients with these diseases. Infectious diseases remain a concern, and emerging pathogens such as Ebola and SARS-CoV-2 will be difficult to handle. At the same time, the utilization of plant virus expression vectors and virus-like nanoparticles have enabled scientists to address global health in a completely new way. Engineered plant viruses are safe, efficacious, stable, biodegradable, and, importantly for middle- and low-income countries, inexpensive to produce. This research topic explores the use of plant virology to address important challenges in human health. Specifically, the application of plant viruses for medical imaging, drug delivery, vaccine development, and cancer therapy will be highlighted.

Dr. Kathleen Hefferon
Dr. Srividhya Venkataraman
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • plant virus
  • pathogens
  • chronic illnesses
  • virus expression vectors
  • virus nanoparticles
  • medical imaging
  • drug delivery
  • vaccine development
  • cancer therapy

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop